580 related articles for article (PubMed ID: 23160112)
1. [Long-term treatment of bipolar disorder: how should we use lithium salts?].
Del Grande C; Muti M; Musetti L; Pergentini I; Corsi M; Turri M; Soldani I; Corsini GU; Dell'Osso L
Riv Psichiatr; 2012; 47(6):515-26. PubMed ID: 23160112
[TBL] [Abstract][Full Text] [Related]
2. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
Vieta E; Angst J; Reed C; Bertsch J; Haro JM;
J Affect Disord; 2009 Nov; 118(1-3):118-23. PubMed ID: 19269690
[TBL] [Abstract][Full Text] [Related]
3. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
Severus WE; Kleindienst N; Evoniuk G; Bowden C; Möller HJ; Bohus M; Frangou S; Greil W; Calabrese JR
J Affect Disord; 2009 Jun; 115(3):466-70. PubMed ID: 19019453
[TBL] [Abstract][Full Text] [Related]
4. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.
Mazza M; Mandelli L; Di Nicola M; Harnic D; Catalano V; Tedeschi D; Martinotti G; Colombo R; Bria P; Serretti A; Janiri L
J Affect Disord; 2009 May; 115(1-2):27-35. PubMed ID: 18845344
[TBL] [Abstract][Full Text] [Related]
5. Oxcarbazepine as add-on treatment in patients with bipolar manic, mixed or depressive episode.
Benedetti A; Lattanzi L; Pini S; Musetti L; Dell'Osso L; Cassano GB
J Affect Disord; 2004 Apr; 79(1-3):273-7. PubMed ID: 15023507
[TBL] [Abstract][Full Text] [Related]
6. Baseline characteristics and outcomes in patients with first episode or multiple episodes of acute mania.
Tohen M; Vieta E; Gonzalez-Pinto A; Reed C; Lin D;
J Clin Psychiatry; 2010 Mar; 71(3):255-61. PubMed ID: 19709503
[TBL] [Abstract][Full Text] [Related]
7. [Methodological approach to inter "guideline" variability in the management of bipolar disorders].
Samalin L; Llorca PM
Encephale; 2012 Apr; 38(2):126-32. PubMed ID: 22516270
[TBL] [Abstract][Full Text] [Related]
8. Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: a 4-year follow-up naturalistic study.
Altamura AC; Mundo E; Dell'Osso B; Tacchini G; Buoli M; Calabrese JR
J Affect Disord; 2008 Sep; 110(1-2):135-41. PubMed ID: 18329720
[TBL] [Abstract][Full Text] [Related]
9. The use of anticonvulsants in the aftermath of mania.
Cookson J; Elliott B
J Psychopharmacol; 2006 Mar; 20(2 Suppl):23-30. PubMed ID: 16551669
[TBL] [Abstract][Full Text] [Related]
10. The association of the effect of lithium in the maintenance treatment of bipolar disorder with lithium plasma levels: a post hoc analysis of a double-blind study comparing switching to lithium or placebo in patients who responded to quetiapine (Trial 144).
Nolen WA; Weisler RH
Bipolar Disord; 2013 Feb; 15(1):100-9. PubMed ID: 23228201
[TBL] [Abstract][Full Text] [Related]
11. Are serum lithium levels related to the polarity of recurrence in bipolar disorders? Evidence from a multicenter trial.
Kleindienst N; Severus WE; Greil W
Int Clin Psychopharmacol; 2007 May; 22(3):125-31. PubMed ID: 17414737
[TBL] [Abstract][Full Text] [Related]
12. Long-term stability of cognitive impairment in bipolar disorder: a 2-year follow-up study of lithium-treated euthymic bipolar patients.
Mur M; Portella MJ; Martínez-Arán A; Pifarré J; Vieta E
J Clin Psychiatry; 2008 May; 69(5):712-9. PubMed ID: 18435565
[TBL] [Abstract][Full Text] [Related]
13. [Management of patients with acute manic or mixed episodes and outcome at three months].
Azorin JM; Luquiens A; Aubrun E; Reed C; Gasquet I; Lukasiewicz M
Encephale; 2010 Jun; 36(3):226-35. PubMed ID: 20620265
[TBL] [Abstract][Full Text] [Related]
14. Anticonvulsants in bipolar disorder.
Singh V; Muzina DJ; Calabrese JR
Psychiatr Clin North Am; 2005 Jun; 28(2):301-23. PubMed ID: 15826734
[TBL] [Abstract][Full Text] [Related]
15. [Predictors of prophylactic response to lithium].
Rohayem J; Baylé JF; Richa S
Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
Revicki DA; Hirschfeld RM; Ahearn EP; Weisler RH; Palmer C; Keck PE
J Affect Disord; 2005 Jun; 86(2-3):183-93. PubMed ID: 15935238
[TBL] [Abstract][Full Text] [Related]
17. Lithium therapy for unipolar and bipolar depression among the middle-aged and older adult patient subpopulation.
Lepkifker E; Iancu I; Horesh N; Strous RD; Kotler M
Depress Anxiety; 2007; 24(8):571-6. PubMed ID: 17133442
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
Vieta E; Suppes T; Eggens I; Persson I; Paulsson B; Brecher M
J Affect Disord; 2008 Aug; 109(3):251-63. PubMed ID: 18579216
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological response in juvenile bipolar disorder subtypes: A naturalistic retrospective examination.
Masi G; Perugi G; Millepiedi S; Mucci M; Pfanner C; Berloffa S; Pari C; Gagliano A; D'Amico F; Akiskal HS
Psychiatry Res; 2010 May; 177(1-2):192-8. PubMed ID: 20381170
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial.
Bowden CL; Mosolov S; Hranov L; Chen E; Habil H; Kongsakon R; Manfredi R; Lin HN
Int Clin Psychopharmacol; 2010 Mar; 25(2):60-7. PubMed ID: 20101186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
